Patent details

Basic Information

Publication number:

EP2958550

PCT Application Number:

IB2014059161

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147106421

PCT Publication Number:

WO2014128661

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ORAL FORMULATION AND SUSPENSION OF AN ONCOLOGY DRUG

French Title of Invention:

FORMULATION ET SUSPENSION À USAGE ORAL D'UN MÉDICAMENT ONCOLOGIQUE

German Title of Invention:

ORALE FORMULIERUNG UND SUSPENSION EINES ONKOLOGISCHEN ARZNEIMITTELS

SPC Number:

Dates

Filing date:

21/02/2014

Grant date:

17/08/2022

EP Publication Date:

30/12/2015

PCT Publication Date:

28/08/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/08/2022

EP B1 Publication Date:

17/08/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/02/2023

Expiration date:

21/02/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/08/2022

 

 

Name:

Sun Pharmaceutical Industries Limited

Address:

SPARC, TANDALJA, Vadodara, Gujarat-390012, India (IN)

Inventor

1

Name:

ROGUE, Vincent

Address:

Switzerland (CH)

2

Name:

DECAUDIN, Céline

Address:

Switzerland (CH)

Priority

Priority Number:

201361768803 P

Priority Date:

25/02/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/10; A61K 47/14; A61K 31/5377; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202233

Publication date:

17/08/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages